UnitedHealth (NYSE:UNH) target price raised to $169.00, issued a report today by Mizuho Securities
- Updated: October 19, 2016
UnitedHealth (NYSE:UNH) had its target bumped up to $169.00 by Mizuho Securities in an issued report announced 10/19/2016. The bumped up target suggests a possible upside of 0.18% based on the company's previous stock price.
Just yesterday UnitedHealth (NYSE:UNH) traded 6.90% higher at $143.39. UnitedHealth’s 50-day moving average is $137.12 and its 200-day moving average is $136.75. The last stock price is up 4.86% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 10,141,914 shares of UNH traded hands, up from an average trading volume of 3,011,390
Recent Performance Chart
UnitedHealth has 52 week low of $107.51 and a 52 week high of $144.48 with a PE ratio of 22.44 and has a market capitalization of $0.
In addition to Mizuho Securities reporting its stock price target, a total of 24 brokerages have issued a ratings update on the company. The average stock price target is $144.17 with 10 brokerages rating the stock a strong buy, 12 brokerages rating the stock a buy, 3 brokerages rating the stock a hold, 1 brokerage rating the stock a underperform, and finally 0 brokerages rating the stock a sell.
Brief Synopsis On UnitedHealth (NYSE:UNH)
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. UnitedHealthcare provides healthcare benefits to a range of customers and markets through its UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, and UnitedHealthcare Global businesses. Optum is a health services business serving the healthcare marketplace, including payers, care providers, employers, governments, life sciences companies and consumers, through its OptumHealth, OptumInsight and OptumRx businesses.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.